SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Firestein GS 2003 Evolving concepts of rheumatoid arthritis. Nature 423: 356361.
  • 2
    Goldring SR 2008 Inflammation-induced bone loss in the rheumatic diseases. In: RosenCJ (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. American Society for Bone and Mineral Research, Washington, DC, USA, 272276.
  • 3
    Jimenez-Boj E, Nöbauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus AH, Kainberger F, Trattnig S, Axmann R, Tsuji W, Hermann S, Smolen J, Schett G 2007 Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 56: 11181124.
  • 4
    Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J, Hieke K 2000 The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxf) 39: 122132.
  • 5
    Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL 2001 The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 44: 20092017.
  • 6
    Aletaha D, Smolen J, Ward MM 2006 Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components. Arthritis Rheum 54: 27842792.
  • 7
    Van der Heijde DM 1995 Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 34: 7478.
  • 8
    Machold KP, Stamm TA, Nell VP, Pflugbeil S, Aletaha D, Steiner G, Uffmann M, Smolen JS 2007 Very recent onset rheumatoid arthritis: Clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxf) 46: 342349.
  • 9
    Weichselbaum A 1878 Die feineren Veränderungen des Gelenkknorpels bei fungöser Synovitis und Karies der Gelenkenden. Arch Pathol Anat Physiol Klin Med 73: 461475.
  • 10
    Bromley M, Woolley DE 1984 Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum 27: 968975.
  • 11
    Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR 1998 Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152: 943951.
  • 12
    Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM 2003 Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 111: 821831.
  • 13
    Tan AL, Tanner SF, Conaghan PG, Radjenovic A, O'Connor P, Brown AK, Emery P, McGonagle D 2003 Role of metacarpophalangeal joint anatomic factors in the distribution of synovitis and bone erosion in early rheumatoid arthritis. Arthritis Rheum 48: 12141222.
  • 14
    Benjamin M, McGonagle D 2001 The anatomical basis for disease localization in seronegative spondylarthropathy at entheses and related sites. J Anat 199: 503526.
  • 15
    Hayer S, Redlich K, Korb A, Hermann S, Smolen J, Schett G 2006 Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritis. Arthritis Rheum 56: 7988.
  • 16
    Pap T, Aupperle KR, Gay S, Firestein GS, Gay RE 2001 Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis Rheum 44: 676681.
  • 17
    Pettit AR, Ji H, von Stechow D, Müller R, Goldring SR, Choi Y, Benoist C, Gravallese EM 2001 TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 159: 16891699.
  • 18
    Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, Steiner G, Smolen JS, Wagner EF, Schett G 2002 Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest 110: 14191427.
  • 19
    Schett G, Stolina M, Bolon B, Middleton S, Adlam M, Brown H, Zhu L, Feige U, Zack DJ 2005 Analysis of the kinetics of osteoclastogenesis in arthritic rats. Arthritis Rheum 52: 31923201.
  • 20
    Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP 2005 Synovial tissue macrophages: A sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis 64: 834838.
  • 21
    Page G, Lebecque S, Miossec P 2002 Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: Correlation with selective chemokine expression in rheumatoid synovium. J Immunol 168: 53335341.
  • 22
    Burman A, Haworth O, Hardie DL, Amft EN, Siewert C, Jackson DG, Salmon M, Buckley CD 2005 A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J Immunol 174: 16931700.
  • 23
    Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, Hamburger J, Ainsworth J, Mathews J, Salmon M, Bowman SJ, Buckley CD 2001 Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum 44: 26332641.
  • 24
    Firestein G, Xu WD, Townsend K, Broide D, Alvaro-Gracia J, Glasebrook A, Zvaifler NJ 1988 Cytokines in chronic inflammatory arthritis: I. Failure to Detect T Cell Lymphokines (Interleukin 2 and Interleukin 3) and Presence of Macrophage Colony-stimulating Factor (CSF-1) and a Novel Mast Cell Growth Factor in Rheumatoid Synovitis. J Exp Med 168: 15731586.
  • 25
    Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR 2000 Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43: 250258.
  • 26
    Shigeyama Y, Pap T, Kunzler P, Simmen BR, Gay RE, Gay S 2000 Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum 43: 25232530.
  • 27
    Stolina M, Adamu S, Ominsky M, Dwyer D, Asuncion F, Geng Z, Middleton S, Brown H, Pretorius J, Schett G, Bolon B, Feige U, Zack D, Kostenuik PJ 2005 RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis. J Bone Miner Res 20: 17561765.
  • 28
    Redlich K, Hayer S, Maier A, Dunstan CR, Tohidast-Akrad M, Lang S, Türk B, Pietschmann P, Woloszczuk W, Haralambous S, Kollias G, Steiner G, Smolen JS, Schett G 2002 Tumor necrosis factor a-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 46: 785792.
  • 29
    Romas E, Sims NA, Hards DK, Lindsay M, Quinn JWM, Ryan PFJ, Dunstan CR, Martin TJ, Gillespie MT 2002 Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am J Pathol 161: 14191427.
  • 30
    Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Robin Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Linh T, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304309.
  • 31
    Kitaura H, Zhou P, Kim HJ, Novack DV, Ross FP, Teitelbaum SL 2005 M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest 115: 34183427.
  • 32
    Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, Van der Heijde D, Zhou L, Tsuji W, Newmark R, on behalf of the Denosumab Rheumatoid Arthritis Study Group 2008 Denosumab treatment effects on structural damage, bone mineral density and bone turover in rheumatoid arthritis. Arthritis Rheum 58: 12991309.
  • 33
    Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S 2000 Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 43: 259269.
  • 34
    Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T 2000 T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 30: 600605.
  • 35
    Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H 2006 Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203: 26732682.
  • 36
    Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T 1999 IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103: 13451352.
  • 37
    Ju JH, Cho ML, Moon YM, Oh HJ, Park JS, Jhun JY, Min SY, Cho YG, Park KS, Yoon CH, Min JK, Park SH, Sung YC, Kim HY 2008 IL-23 induces receptor activator of NF-kappaB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model. J Immunol 181: 15071518.
  • 38
    Abu-Amer Y, Erdmann J, Alexopoulou L, Kollias G, Ross FP, Teitelbaum SL 2000 Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J Biol Chem 275: 2730727310.
  • 39
    Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL 1997 Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 100: 15571565.
  • 40
    Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL 2000 TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106: 14811488.
  • 41
    Li P, Schwarz EM, O'Keefe R, Ma L, Boyce BF, Xing L 2004 RANK signaling is not required for TNF-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. J Bone Miner Res 19: 207213.
  • 42
    Herman S, Mueller R, Kronke G, Zwerina J, Redlich K, Hueber A, Gelse H, Neumann E, Mueller-Ladner U, Schett G 2008 OSCAR, a key co-stimulation molecule for osteoclasts, is induced in patients with rheumatoid arthritis. Arthritis Rheum 58: 30413050.
  • 43
    Zwerina J, Redlich K, Polzer K, Joosten L, Kroenke G, Distler J, Hess A, Pundt N, Pap P, Hoffmann O, Gasser J, Scheinecker C, Smolen JS, Van den Berg W, Schett G 2007 TNF-induced Structural Joint Damage Is Mediated By Interleukin-1. Proc Nat Acad Sci USA 2007. Proc Natl Acad Sci USA 104: 1174211747.
  • 44
    Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL 2005 IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 115: 282290.
  • 45
    Gillespie MT 2007 Impact of cytokines and T lymphocytes upon osteoclast differentiation and function. Arthritis Res Ther 9: 103.
  • 46
    Quinn JM, Sims NA, Saleh H, Mirosa D, Thompson K, Bouralexis S, Walker EC, Martin TJ, Gillespie MT 2008 IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in mice. J Immunol 181: 57205729.
  • 47
    Horwood NJ, Elliott J, Martin TJ, Gillespie MT 2001 IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 166: 49154921.
  • 48
    Goldring SR, Goldring MB 2007 Eating bone or adding it: The Wnt pathway decides. Nat Med 13: 133134.
  • 49
    Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heijde D, Landewe R, Lacey D, Richards WG, Schett G 2007 Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13: 156163.
  • 50
    Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G 2005 Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8: 751764.